Efficacy of abatacept or infliximab treatment in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a 1-year double-blind, randomized, placebo-controlled trial

被引：0
|
作者：
Bessette, L. [1 ]
Homik, J. [2 ]
Dougados, M. [3 ]
Keiserman, M. [4 ]
Codding, C. [5 ]
Songcharoen, S.
Berman, A. [6 ]
Nayiager, S. [7 ]
Saldate, C. [8 ]
Aranda, R. [9 ]
Becker, J. [9 ]
Li, T. [9 ]
Lin, C. [10 ]
Cornet, P. L. N. [11 ]
Schiff, M. [12 ]
机构：
[1] Univ Quebec, Ctr Hosp, Ste Foy, PQ G1V 2M3, Canada
[2] Univ Alberta, Edmonton, AB, Canada
[3] Hop Cochin, F-75674 Paris, France
[4] Pontificia Univ Catolica, Sch Med, Porto Alegre, RS, Brazil
[5] Hlth Res Oklahoma, Oklahoma City, OK USA
[6] Ctr Med Privade Reumatol, San Miguel De Tucuman, Argentina
[7] St Augustines Med Ctr, Durban, South Africa
[8] Ctr Investigac Noroeste, Tijuana, Mexico
[9] Bristol Myers Squibb Co, Princeton, NJ USA
[10] Bristol Myers Squibb Co, Hopewell Jct, NY USA
[11] Bristol Myers Squibb Co, Shanghai, Peoples R China
[12] Denver Arthritis Clin, Denver, CO USA
来源：
JOURNAL OF RHEUMATOLOGY | 2008年 / 35卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1178 / 1179
页数：2
相关论文
共 50 条
  • [21] A double-blind placebo-controlled randomized trial of oral saffron in the treatment of rheumatoid arthritis
    Sahebari, Maryam
    Heidari, Hossein
    Nabavi, Shima
    Khodashahi, Mandana
    Rezaieyazdi, Zahra
    Dadgarmoghaddam, Maliheh
    Hosseinzaheh, Hossein
    Abbasi, Shaghayegh
    Hashemzadeh, Kamila
    AVICENNA JOURNAL OF PHYTOMEDICINE, 2021, 11 (04) : 332 - 342
  • [22] A Double-Blind Randomized Placebo-Controlled Trial Of Lovastatin in Patients with Rheumatoid Arthritis.
    Aranow, Cynthia
    Cush, John J.
    Bolster, Marcy B.
    Striebich, Christopher C.
    Dall'Era, Maria
    Mackay, Meggan
    Olech, Ewa
    Frech, Tracy M.
    Box, J.
    Keating, Richard M.
    Wasko, Mary Chester M.
    St Clair, E. William
    Kivitz, Alan
    Diamond, Betty
    Davidson, Anne
    Spychala, Meagan
    Goldmuntz, Ellen A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1181 - S1182
  • [23] Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial
    Rigby, W.
    Tony, H-P
    Oelke, K.
    Combe, B.
    Laster, A.
    von Muhlen, C. A.
    Fisheleva, E.
    Martin, C.
    Travers, H.
    Dummer, W.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (02): : 350 - 359
  • [24] A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis
    Abe, T
    Takeuchi, T
    Miyasaka, N
    Hashimoto, H
    Kondo, H
    Ichikawa, Y
    Nagaya, L
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 37 - 44
  • [25] Safety of abatacept in rheumatoid arthritis patients in five double-blind, placebo-controlled trials
    Moreland, L
    Kaine, J
    Espinoza, L
    McCann, T
    Aranda, R
    Becker, JC
    Kremer, J
    Bingham, C
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S350 - S350
  • [26] Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 study
    Yang, Yue
    Li, Jingyang
    Liu, Ju
    Liu, Lin
    Wang, Yongfu
    Hu, Jiankang
    Li, Zhijun
    Gu, Jieruo
    Zhang, Xiao
    Xiao, Zhengyu
    Zheng, Junjie
    Liu, Lin
    Li, Zhanguo
    Wei, James Cheng-Chung
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2024, 42
  • [27] Randomized, double-blind, placebo-controlled trial of infliximab in patients with polymyositis and dermatomyositis
    Coyle, K.
    Pokrovnichka, A.
    French, K.
    Joe, G.
    Shrader, J.
    Swan, L.
    Cabalar, I.
    Harris-Love, M.
    Plotz, P.
    Miller, F.
    Gourley, M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S923 - S924
  • [28] Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial
    van Vollenhoven, Ronald F.
    Keystone, Edward Clark
    Strand, Vibeke
    Pacheco-Tena, Cesar
    Vencovsky, Jiri
    Behrens, Frank
    Racewicz, Arthur
    Zipp, Daniela
    Rharbaoui, Faiza
    Wolter, Ralf
    Knierim, Luise
    Schmeidl, Rainer
    Zhou, Xuefei
    Aigner, Silke
    Daelken, Benjamin
    Wartenberg-Demand, Andrea
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (04) : 495 - 499
  • [29] Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial
    Zamani, B.
    Golkar, H. R.
    Farshbaf, S.
    Emadi-Baygi, M.
    Tajabadi-Ebrahimi, M.
    Jafari, P.
    Akhavan, R.
    Taghizadeh, M.
    Memarzadeh, M. R.
    Asemi, Z.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (08)
  • [30] The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial
    Emery, P
    Fleischmann, R
    Filipowicz-Sosnowska, A
    Schechtman, J
    Szczepanski, L
    Kavanaugh, A
    Racewicz, AJ
    Van Vollenhoven, RF
    Li, NF
    Agarwal, S
    Hessey, EW
    Shaw, TM
    ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1390 - 1400
12345